Related Experiment Video
Updated: Dec 22, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases
Eli Stahl1, Giulia Roda2, Amanda Dobbyn1
1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
This study implicates the HLA locus in collagenous colitis (CC) pathogenesis and reveals shared genetic risks with celiac disease, Crohn's disease (CD), and ulcerative colitis (UC). These findings support observed clinical comorbidities in immune-mediated disorders.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Collagenous colitis (CC) is an inflammatory bowel disorder with an unclear cause.
- CC pathogenesis may involve immune responses linked to HLA, genetics, and environmental factors.
Purpose of the Study:
- To conduct a genetic association study in CC patients.
- To investigate shared genetic underpinnings between CC and other immune-mediated diseases like Crohn's disease (CD), ulcerative colitis (UC), and celiac disease.
Main Methods:
- Genotyping of 804 CC tissue samples using Illumina Immunochip.
- Meta-analysis with independent cohorts and polygenic risk score calculation.
- Cross-phenotype analyses and assessment of expression quantitative trait loci (eQTLs) in various cell types.
Main Results:
- Significant association of three HLA alleles (HLA-B∗08:01, HLA-DRB1∗03:01, HLA-DQB1∗02:01) with increased CC risk.
- Identification of a protective effect for HLA-DRB1∗04:01.
- Strong association of polygenic risk scores with CC risk and enrichment of eQTLs in CC-susceptibility variants.
Conclusions:
- The HLA locus is strongly implicated in CC pathogenesis.
- Potential non-HLA mechanisms contribute to CC development.
- Shared genetic risk between CC, celiac disease, CD, and UC supports clinical comorbidity observations.
More Related Videos
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Type IV Collagen of Basal Lamina
A type IV collagen molecule has six alpha chains which can...

